Pravastatin and rosiglitazone combination therapy increase the expression of ABCA1 in monocytes of coronary heart disease

Basic & Clinical Medicine ›› 2010, Vol. 30 ›› Issue (10): 1096-1097.

• 研究短文 • Previous Articles Next Articles

Pravastatin and rosiglitazone combination therapy increase the expression of ABCA1 in monocytes of coronary heart disease

Hua-bo LI

Hubei Nationality College

Received:2009-07-07 Revised:2010-03-13 Online:2010-10-05 Published:2010-10-05
Contact: Hua-bo LI

Abstract

CLC Number:

R541.1

Hua-bo LI. Pravastatin and rosiglitazone combination therapy increase the expression of ABCA1 in monocytes of coronary heart disease[J]. Basic & Clinical Medicine, 2010, 30(10): 1096-1097.

[1]	. Chemokine receptor 2 inhibitor alleviates renal interstitial fibrosis in unilateral ureteral obstruction mouse model [J]. Basic & Clinical Medicine, 2019, 39(4): 461-466.
[2]	. Rosiglitazone alleviates vascular endothelial dysfunction in type 2 diabetic rats [J]. Basic & Clinical Medicine, 2017, 37(11): 1585-1589.
[3]	Yu GAO; Hui-juan MA; Jing WANG; Dong-ming QU; Guang-yao SONG; Shu-guo HU. Rosiglitazone up-regulates expression of CPTⅠand PPARγ in skeletal muscles of aged rat fed high-fat diets [J]. Basic & Clinical Medicine, 2010, 30(9): 935-939.
[4]	Peng LIU; Gong-xin LI; Ying-feng LIU; Fei MIAO; Lin XU; Huan ZHAO; Zi-wei ZHANG. Effect of oxidized HDL on ABCA1 in human umbilical vein endothelial cells [J]. Basic & Clinical Medicine, 2010, 30(4): 419-420.
[5]	Quan HE; Han LEI; Qing LIU; Shu QIN; Kang-hua MA; Xi WANG. Effect of rosiglitazone on no-reflow after reperfusion in rats with AMI [J]. Basic & Clinical Medicine, 2009, 29(8): 816-820.
[6]	Gen-yang CHENG; Jian-sheng LI; Zhang-suo LIU. Inhibiting effects of rosiglitazone on expression of TGF-β1 and FIBRONECTIN in rat hepatocytes cultured with CsA [J]. Basic & Clinical Medicine, 2009, 29(2): 198-200.
[7]	Liang-hong WU; Nan-sheng CHENG; Fan YANG; Xian-ze XIONG; Da-peng WEI; Qing-jie XIA. The effect of PPAR-γ ligand RGZ on expression in transplantation tumor of Cholangiocarcinoma [J]. Basic & Clinical Medicine, 2008, 28(2): 128-132.

Pravastatin and rosiglitazone combination therapy increase the expression of ABCA1 in monocytes of coronary heart disease

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 7

Recommended Articles

Metrics

Comments